---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-001401"
form_type: "8-K"
ticker: "MGRX"
cik: "0001938046"
company_name: "MANGOCEUTICALS, INC."
filed_at: "2025-01-08T23:59:59+00:00"
generated_at: "2026-05-28T07:15:27.729862+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Mangoceuticals raises $900k via Series B Preferred and warrants for 1.188M shares

## Summary
- Closed four SPAs from Dec 31, 2024 through Jan 6, 2025, selling 900 shares of Series B Preferred at $1,000 each for $900k total.
- Issued warrants to purchase up to 1,188,000 shares, exercisable at 105% of 10-day VWAP (range $2.57–$2.61), 5-year term.
- Warrants exercisable after 180 days; include dilutive issuance price adjustments and cashless exercise if registration not effective.
- Series B Preferred convertible at $1,100 stated value, floor price $2.25; 440,000 common shares issuable on full conversion.
- Offering of 1,250 Series B Preferred shares closed; securities issued under Section 4(a)(2)/Reg D, no public offering.

## SEC filing metadata
- accession: 0001493152-25-001401
- form_type: 8-K
- ticker: MGRX
- cik: 0001938046
- company_name: MANGOCEUTICALS, INC.
- filed_at: 2025-01-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1938046/000149315225001401/0001493152-25-001401-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1938046/000149315225001401/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-001401
- JSON: https://secwatch.observer/filing/0001493152-25-001401.json
- Plain text: https://secwatch.observer/filing/0001493152-25-001401.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.